Searchable abstracts of presentations at key conferences in endocrinology

ea0090ep8 | Adrenal and Cardiovascular Endocrinology | ECE2023

Metabolic changes in transgender people after gender-affirming hormone therapy

Toscano Esteban Sanchez , Gavira Isabel Mateo , Riscart Jesus Dominguez

Introduction: Demand for health care for transsexual people has increased exponentially in last years, especially among adolescents and young adults. Gender-affirming hormones (GAHs) are initiated to accommodate secondary sexual characteristics to the desired sex. Published studies about metabolic repercussion of GAHs are heterogeneous and report diverse results. Our objective is to evaluate the effect of GAHs on cardiovascular risk factors in transsexual population treated in...

ea0090ep446 | Diabetes, Obesity, Metabolism and Nutrition | ECE2023

Clinical and genetic profile in a cohort of adults with morbid obesity

Toscano Esteban Sanchez , Lucena Morales Cristian Jesus , Riscart Jesus Dominguez , Escandon Laura Larran , Gavira Isabel Mateo

Introduction: There have been more than 130 genes described in relation with the development of obesity, which condition hyperphagia and early obesity. The aim of this study is to determine the prevalence of genetic alterations in a cohort of patients with morbid obesity.Materials and Methods: We designed a descriptive cross-sectional study for a cohort of subjects with obesity grade III or higher (BMI ≥40 kg/m2), treated at endocrinolog...

ea0090ep665 | Environmental Endocrinology | ECE2023

Psychosocial profile of transgender population attended in a gender identity unit

Toscano Esteban Sanchez , Zayas Aguilar Irene , Mateo Gavira Isabel , Larran Escandon Laura , Vega Trujillo Lopez Maria de la

Introduction: Transgender people are a diverse population affected by a variety of negative health indicators. Studies report, among other conditions, a high prevalence of mental health problems and substance abuse. However, there are still health issues that have been poorly analyzed and long-term longitudinal follow-up studies are scarce.Objective: The aim of this study is to deep into the demographic characteristics and the psychosocial profile of tra...

ea0081ep346 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

A new case of hypoglycemia of unrelated etiology.

Medina Rivero Daniel , Mateo Gavira Isabel , Sanchez Toscano Esteban

Male, 29 years old. Go to consultations in our center for a second opinion for assessment of hypoglycemia. The patient has reported, for 3 years, symptoms consisting of episodes of dizziness and headache predominantly during the day, which subside after eating food, and which increase in frequency in relation to exercise. He provides capillary glycaemia objectified in family glucometer between 40-70 mg/dl coinciding with the episodes. The patient was initially treated at anoth...

ea0081p572 | Diabetes, Obesity, Metabolism and Nutrition | ECE2022

Telephone support program for patients with type 2 diabetes under treatment with insulin glargine 300 u/ml (t-coach) in the area of cadiz (spain)

Cornejo Dominguez Jesus Manuel , Sanchez Toscano Esteban , Mateo Gavira Maria Isabel , Garcia Garcia-Doncel Lourdes , San Laureano Carral Florentino

Introduction: The T-Coach® telephone support program for patients with type 2 diabetes (DM2) treated with insulin glargine 300 u/ml, facilitates dose adjustments of basal insulin therapy through regular telephone consultations and offers diabetes education in order to improve empowerment of the patient. Objective: To assess the usefulness of the T-Coach® program in metabolic control and degree of satisfaction in patients with T2DM.Patients and ...

ea0070aep325 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Evaluation of the effects of phone support programme for patients with type 2 diabetes in treatment with insulin glargine 300 u/ml (T-coah)

Lara-Barea Almudena , Mateo-Gavira Isabel , Sánchez-Toscano Esteban , Medina-Rivero Daniel , Aguilar-Diosdado Manuel

Introduction: T-Coach program is a phone support platform for patients with type 2 diabetes (T2D) treated with insulin glargine 300 U/ml in order to adjust basal insulin dose, reinforce diabetes education and encourage patients to get their goals through regular phone calls. The aim of the study was to evaluate T-Coach program effectiveness in metabolic control and level of satisfaction in patients with T2D.Methods: We conducted a retrospe...

ea0070aep351 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Evaluation of clinical factors predictive of diabetes remission after bariatric surgery

Lara-Barea Almudena , Mateo-Gavira Isabel , Sánchez-Toscano Esteban , Medina Rivero Daniel , Aguilar Diosdado Manuel

Introduction: Bariatric surgery is an effective treatment in order to achieve an important weight loss and improvement of metabolic comorbidities. This study aimed to assess the clinical factors that can influenced on evolution of type 2 diabetes (T2D) and obesity patients after bariatric surgery.Methods: We conducted a cohort study with a sample of patients with type 2 diabetes and class II obesity or above who underwent bariatric surgery at Hospital Un...

ea0063p971 | Diabetes, Obesity and Metabolism 3 | ECE2019

Are fast insulin analogues fast enough? Switching to faster aspart may reduce glycemic variability and the risk of hypoglycemia in type 1 diabetic patients on sensor-augmented insulin pump therapy

Nivelo-Rivadeneira Manuel Esteban , Kuzior Agnieszka , Fernandez-Trujillo-Comenge Paula Maria , Santana-Suarez Ana Delia , Acosta-Calero Carmen , Diaz-Moreno Macarena , Medina-Sanchez Almudena , Martinez-Martin Francisco Javier

Aim: Comparing the effect of Faster Aspart insulin (Fiasp®) with previous insulin analogues (aspart, lispro) in type I diabetic patients with sensor-augmented pump therapy.Methods: Patients with Minimed Paradigm® insulin pumps, Enlite® sensors and Guardian® software (able to automatically stop the pump infusion to prevent hypoglycemia) were switched from previous insulin to Faster Aspart. Da...

ea0081p32 | Calcium and Bone | ECE2022

Calcifediol 0.266 mg supplementation in adult population with 25(OH)D deficiency: 4 months results

Jodar Esteban , Guerra Lopez Pedro , Vega-Gil Noelia , Sanchez Santiago Blanca , Zorrilla Martinez Inaki , Jimenez-Mercado Mario , Garcia-Bea Aintzane , Landeta Manzano Araitz , Campo Hoyos Cristina , Frias Iniesta Jesus

Introduction: Prevalence of vitamin D deficiency is relatively high worldwide, it is associated with poor skeletal health and has recently been related to other extra-skeletal diseases, probably due to its immunomodulatory effects. Detection and treatment of asymptomatic hypovitaminosis D in healthy adult population is especially relevant to attempt to optimize the overall functioning of the human body.Objectives: To assess the percentage of adult health...

ea0099p291 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Endoscopic argon plasma coagulation (APC) treatment for dumping syndrome and post-bariatric hypoglucemia in patients with ROUX-EN-Y gastric bypass

Mera Carreiro Sara , Bernaldo Madrid Blanca , Rodriguez Carrillo Clara , Espinosa De Los Monteros Patricia , Avila Anton Laura , Sanchez-Maroto Garcia Noelia , Martinez Suero Laura , Rueda Ortin Teresa , Miguel Esteban Lopez-Jamar Jose , Angel Rubio Herrera Miguel

Background: Dumping syndrome (DS) and post-bariatric hypoglycemia (PBH) are some of the most challenging problems encountered during the follow-up of bariatric surgery (BS), especially after Roux-en-y gastric bypass (yRGB). When pharmacological and dietary treatment fail to control DS and PBH, surgical revision is often the next therapeutic step. Endoscopic treatment with argon plasma coagulation (APC) may be an alternative treatment by reducing the diameter of the gastro-jeju...